Search

Your search keyword '"Hoffman, Sara A."' showing total 171 results

Search Constraints

Start Over You searched for: Author "Hoffman, Sara A." Remove constraint Author: "Hoffman, Sara A."
171 results on '"Hoffman, Sara A."'

Search Results

1. AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases

2. Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitis

3. OS-029 Analytical and clinical validation of AIM-NASH: a digital pathology tool for artificial intelligence-based measurement of non-alcoholic steatohepatitis histology

4. To do no harm — and the most good — with AI in health care

9. Human-interpretable image features derived from densely mapped cancer pathology slides predict diverse molecular phenotypes

10. Analytical and clinical validation of AIM-NASH: a digital pathology tool for artificial intelligence-based measurement of non-alcoholic steatohepatitis histology

11. AI-based histologic scoring enables automated and reproducible assessment of enrollment criteria and endpoints in NASH clinical trials

12. Attityder kring döden i samband med palliativ vård : En litteraturöversikt

19. Retrospective AI-based measurement of NASH histology (AIM-NASH) analysis of biopsies from Phase 2 study of Resmetirom confirms significant treatment-induced changes in histologic features of non-alcoholic steatohepatitis

21. Abstract 471: AIM PD-L1-NSCLC: Artificial intelligence-powered PD-L1 quantification for accurate prediction of tumor proportion score in diverse, multi-stain clinical tissue samples

22. Abstract CT112: AI-powered and manual assessment of PD-L1 are comparable in predicting response to neoadjuvant atezolizumab in patients (pts) with resectable non-squamous, non-small cell lung cancer (NSCLC)

24. Evidence-Based Practice

26. Abstract LB016: Deep learning identifies pathobiological features within H&E images associated with genomic alterations and progression on anti-PD(L)1 in HUDSON, an AstraZeneca-sponsored Phase II clinical trial

28. Professional merit in engineering career advancement: Student perspectives and critiques.

41. Mobilapplikationer- framtidens verktyg för patienten i dennes livsstilsförändring?

42. Breast cancer survivors' preferences for social support features in technology-supported physical activity interventions: findings from a mixed methods evaluation.

44. Breast cancer survivors’ preferences for social support features in technology-supported physical activity interventions: findings from a mixed methods evaluation

46. Det sociala arbetet i skolan. Med fokus på lärares subjektiva upplevelser och erfarenheter

48. A qualitative exploration of social and environmental factors affecting diet and activity in knee replacement patients.

49. Tillgänglighet som fenomen : Hur säljare av komplexa IT-lösningar upplever tillgänglighet

50. Contra Costa expects further economic gains

Catalog

Books, media, physical & digital resources